NA
NVS icon

Navellier & Associates’s Novartis NVS Stock Holding History

Navellier & Associates’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-100
Closed -$8K – 283
2015
Q4 		$8K Buy
100
+71
+245% +$5.64K ﹤0.01% 216
2015
Q3 		$2K Sell
29
-7,406
-100% -$659K ﹤0.01% 293
2015
Q2 		$655K Buy
7,435
+566
+8% +$51.9K 0.06% 163
2015
Q1 		$607K Sell
6,869
-437
-6% -$38.8K 0.06% 167
2014
Q4 		$607K Sell
7,306
-61
-0.8% -$5.06K 0.03% 165
2014
Q3 		$621K Sell
7,367
-959
-12% -$77.6K 0.03% 150
2014
Q2 		$675K Sell
8,326
-342
-4% -$26.9K 0.03% 146
2014
Q1 		$660K Sell
8,668
-422
-5% -$30.8K 0.03% 132
2013
Q4 		$655K Sell
9,090
-426,274
-98% -$29.6M 0.03% 137
2013
Q3 		$29.9M Sell
435,364
-9,249
-2% -$612K 0.88% 62
2013
Q2 		$28.2M Buy
+444,613
New +$28.9M 1.34% 39

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
IC
Institutional Capital Chicago, Illinois $6.75B AUM 3.51% 1-Year Est. Return

Navellier & Associates's NVS Position: Q1 2016 in Review

Navellier & Associates sold out of Novartis (NVS) in Q1 2016, closing a stake of 100 shares — an estimated $8K sold.

Navellier & Associates first reported a position in NVS in Q2 2013 and held it in 11 quarters. The position peaked at $29.9M in Q3 2013. 876 funds tracked by Wall St. Rank hold NVS as of Q1 2016.

  • Navellier & Associates reported no remaining Novartis position as of Q1 2016 after selling out during the quarter.
  • Navellier & Associates sold 100 Novartis shares in Q1 2016, an estimated $8K.
  • Navellier & Associates first reported a position in Novartis in Q2 2013 and held it in 11 quarters.
  • Navellier & Associates's Novartis position peaked at $29.9M in Q3 2013.
  • 876 funds tracked by Wall St. Rank held Novartis as of Q1 2016.

Based on Navellier & Associates's 13F filing for Q1 2016, filed 13 May 2016.